Abstract
Background
Various factors regarding the biological state of tumors or the nutritional status of patients have been reported individually to correlate with prognosis. Identification of defined patient groups based on a prognostic score may improve the prediction of survival and individualization of therapy. The aim of the present study was to identify clinically useful parameters obtainable before treatment that could be used for predicting clinical outcomes in patients with gastric cancer.
Methods
In 357 consecutive patients who had been treated for potentially curable gastric cancer, we retrospectively analyzed the following clinicopathological factors: sex, age, body mass index, body weight changes, hemoglobin, white blood cell count, neutrophil to lymphocyte (N/L) ratio, serum C-reactive protein (CRP), serum albumin, serum cholinesterase, tumor location, tumor size, histology, and clinical tumor node metastasis (TNM) stage. Factors related to prognosis were evaluated by univariate and multivariate analysis.
Results
From univariate analysis, significant differences in survival were found for age, hemoglobin, N/L ratio, serum CRP, serum albumin, serum cholinesterase, tumor size, and clinical T and N grouping. N/L ratio, tumor size, and clinical T grouping were identified as independent prognostic indicators in multivariate analysis. A prognostic score was constructed using these variables to estimate the probability of death. The model gave an area under the receiver operating characteristic curve of 0.85 for prediction of death at 5 years.
Conclusions
This model based on N/L ratio, tumor size, and clinical T grouping before treatment offers a very informative scoring system for predicting prognosis of gastric cancer.
Similar content being viewed by others
References
Noguchi Y, Imada T, Matsumoto A et al (1989) Radical surgery for gastric cancer—a review of the Japanese experience. Cancer 64:2053–2062
Maruyama K, Okabayashi K, Kinoshita T (1987) Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg 11:418–425
Akoh JA, Macintyre IM (1992) Improving survival in gastric cancer: review of 5-year survival rates in English language publications from 1970. Br J Surg 79:293–299
Balkwill F, Mantovani A (2000) Inflammation and cancer: back to Virchow? Lancet 357:539–545
Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860–867
International Union Against Cancer (1997) TNM Classification of Malignant Tumors, 5th edn. Wiley-Liss, New York
Habermann CR, Weiss F, Riecken R et al (2004) Preoperative staging of gastric adenocarcinoma: comparison of helical CT and endoscopic US. Radiology 230:465–471
Bentrem D, Gerdes H, Tang L et al (2007) Clinical correlation of endoscopic ultrasonography with pathologic stage and outcome in patients undergoing curative resection for gastric cancer. Ann Surg Oncol 14:1853–1859
Kim JP, Lee JH, Kim SJ et al (1998) Clinicopathological characteristics and prognostic factors in 10783 patients with gastric cancer. Gastric Cancer 1:125–133
Siewert JR, Böttcher K, Stein HJ et al (1998) Relevant prognostic factors in gastric cancer. Ten-year results of the German Gastric Cancer Study. Ann Surg 228:449–461
Yasui W, Oue N, Aung PP et al (2005) Molecular-pathological prognostic factors of gastric cancer: a review. Gastric Cancer 8:86–94
Ishizuka M, Nagata H, Takagi K et al (2007) Inflammation-based prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer. Ann Surg 246:1047–1051
Sharma R, Hook J, Kumar M et al (2008) Evaluation of an inflammation-based prognostic score in patients with advanced ovarian cancer. Eur J Cancer 44:251–256
Crumley AB, McMillan DC, McKerman M et al (2006) An elevated C-reactive protein concentration prior to surgery predicts poor cancer-specific survival in patients undergoing resection for gastro-oesophageal cancer. Br J Cancer 94:1568–1571
Canna K, McMillan DC, McKee RF et al (2006) Evaluation of a cumulative prognostic score based on systemic inflammatory response in patients undergoing potentially curative surgery for colorectal cancer. Br J Cancer 30:1707–1709
Lamb GW, McMillan DC, Ramsey S et al (2006) The relationship between the preoperative systemic inflammatory response and cancer-specific survival in patients undergoing potentially curative resection for renal cell cancer. Br J Cancer 94:781–784
Sarraf KM, Belcher E, Raevsky E et al (2009) Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. J Thorac Cardiovasc Surg 137:425–428
Cho H, Hur HW, Kim SW et al (2009) Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment. Cancer Immunol Immunother 58:15–23
Yamanaka T, Matsumoto S, Teramukai S et al (2007) The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer. Oncology 73:215–220
Hirashima M, Higuchi S, Sakamoto K et al (1998) The ratio of neutrophils to lymphocytes and the phenotypes of neutrophils in patients with early gastric cancer. J Cancer Res Clin Oncol 124:329–334
Walsh SR, Cook J, Goulder F et al (2005) Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 91:181–184
Zahorec R (2001) Ratio of neutrophil to lymphocyte counts—rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy 102:5–14
Jilma B, Blann A, Pernerstorfer T et al (1999) Regulation of adhesion molecules during human endotoxemia. No acute effects of aspirin. Am J Respir Crit Care Med 159:857–863
Adachi Y, Oshiro T, Mori M et al (1997) Tumor size as a simple prognostic indicator for gastric carcinoma. Ann Surg Oncol 4:137–140
Giuliani A, Caporale A, Di Bari M et al (2003) Maximum gastric cancer diameter as a prognostic indicator: univariate and multivariate analysis. J Exp Clin Cancer Res 22:531–538
Michelassi F, Takahashi DM Jr, Pantalone D et al (1994) Analysis of clinicopathologic prognostic features in patients with gastric adenocarcinoma. Surgery 116:804–809
Yokota T, Ishiyama S, Saito T et al (2002) Is tumor size a prognostic indicator for gastric carcinoma? Anticancer Res 22:3673–3677
Yu CC, Levision DA, Dunn JA et al (1995) Pathological prognostic factors in the second British Stomach Cancer Group trial of adjuvant therapy in resectable gastric cancer. Br J Cancer 71:1106–1110
Jun KH, Junq H, Baek JM et al (2009) Does tumor size have an impact on gastric cancer? A single institute experience. Langenbecks Arch Surg 394:631–635
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mohri, Y., Tanaka, K., Ohi, M. et al. Prognostic Significance of Host- and Tumor-Related Factors in Patients with Gastric Cancer. World J Surg 34, 285–290 (2010). https://doi.org/10.1007/s00268-009-0302-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-009-0302-1